Friendships strongly influence physical activity levels among children even as young as 5 to 12 years, a new study reports.
Studies of adolescents and adults have demonstrated an association between social networks and obesity. Children’s social networks may have as strong an influence on behavior as adolescent networks, the researchers say.
Researchers evaluated data collected at 3 points during 2 structured, 12-week afterschool programs from 81 public school students aged 5 years or older. They determined each child’s social network by private interview and recorded physical activity with Actigraph GT1M accelerometers, using proportion of time spent in moderate to vigorous physical activity as an outcome measure. They analyzed the social network and activity data longitudinally using the SIENA version 4.0 system.
Children participating in the afterschool programs consistently adjusted the time they spent in moderate to vigorous physical activity by 10% or more in imitation of their immediate circle of friends, defined as 4 to 6 other children. Age and obesity had a small effect on activity; sex of the child had no direct effect.
Activity level did not influence formation or termination of friendships. Both active and inactive children had about the same number of friends and were about as likely to be chosen as friends.
Contrary to previous research, the study did not find that children chose others of comparable weight as friends. They were more likely to gravitate toward children of similar age, school, sex, and race than activity or weight.
The researchers speculate that afterschool programs might build on the study’s findings by embedding sedentary children in groups of very active children in the hope that the inactive children would increase their activity level by forming friendships with their active peers. Such an intervention would require maintaining a large enough ratio of active to inactive children to prevent the active children from reducing their activity levels in imitation of their less active friends.
Go back to the current issue of the eConsult.
Social networks can boost physical activity
Friendships strongly influence physical activity levels among children even as young as 5 to 12 years, a new study reports. The findings may point to new ways of fighting obesity. More >>
Friendships strongly influence physical activity levels among children even as young as 5 to 12 years, a new study reports.
Studies of adolescents and adults have demonstrated an association between social networks and obesity. Children’s social networks may have as strong an influence on behavior as adolescent networks, the researchers say.
Researchers evaluated data collected at 3 points during 2 structured, 12-week afterschool programs from 81 public school students aged 5 years or older. They determined each child’s social network by private interview and recorded physical activity with Actigraph GT1M accelerometers, using proportion of time spent in moderate to vigorous physical activity as an outcome measure. They analyzed the social network and activity data longitudinally using the SIENA version 4.0 system.
Children participating in the afterschool programs consistently adjusted the time they spent in moderate to vigorous physical activity by 10% or more in imitation of their immediate circle of friends, defined as 4 to 6 other children. Age and obesity had a small effect on activity; sex of the child had no direct effect.
Activity level did not influence formation or termination of friendships. Both active and inactive children had about the same number of friends and were about as likely to be chosen as friends.
Contrary to previous research, the study did not find that children chose others of comparable weight as friends. They were more likely to gravitate toward children of similar age, school, sex, and race than activity or weight.
The researchers speculate that afterschool programs might build on the study’s findings by embedding sedentary children in groups of very active children in the hope that the inactive children would increase their activity level by forming friendships with their active peers. Such an intervention would require maintaining a large enough ratio of active to inactive children to prevent the active children from reducing their activity levels in imitation of their less active friends.
Go back to the current issue of the eConsult.
Incorporating objective testing to add value to an ADHD diagnosis
April 25th 2024Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.
Food Insecurity and the Dangers of Infant Formula Dilution
January 30th 2023FDA approves tovorafenib for most common form of childhood brain tumor
April 24th 2024This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.
Demystifying Infant Formula
October 11th 2022Ustekinumab biosimilar approved to treat moderate to severe plaque psoriasis
April 23rd 2024The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
April 23rd 2024Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.
Incorporating objective testing to add value to an ADHD diagnosis
April 25th 2024Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.
Food Insecurity and the Dangers of Infant Formula Dilution
January 30th 2023FDA approves tovorafenib for most common form of childhood brain tumor
April 24th 2024This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.
Demystifying Infant Formula
October 11th 2022Ustekinumab biosimilar approved to treat moderate to severe plaque psoriasis
April 23rd 2024The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
April 23rd 2024Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.